Classical Swine Fever Vaccines Market - Global Outlook and Forecast 2021-2027

Publisher Name :
Date: 09-Sep-2021
No. of pages: 109

This report contains market size and forecasts of Classical Swine Fever Vaccines in global, including the following market information:

Global Classical Swine Fever Vaccines Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Classical Swine Fever Vaccines Market Sales, 2016-2021, 2022-2027, (M Doses)

Global top five Classical Swine Fever Vaccines companies in 2020 (%)

The global Classical Swine Fever Vaccines market was valued at 172.9 million in 2020 and is projected to reach US$ 212.2 million by 2027, at a CAGR of 5.3% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Classical Swine Fever Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Classical Swine Fever Vaccines Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

Global Classical Swine Fever Vaccines Market Segment Percentages, By Type, 2020 (%)

- Tissue Culture Origin

- Cell Line Origin

Global Classical Swine Fever Vaccines Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

Global Classical Swine Fever Vaccines Market Segment Percentages, By Application, 2020 (%)

- Government Tender

- Market Sales

Global Classical Swine Fever Vaccines Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

Global Classical Swine Fever Vaccines Market Segment Percentages, By Region and Country, 2020 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Classical Swine Fever Vaccines revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Classical Swine Fever Vaccines revenues share in global market, 2020 (%)

Key companies Classical Swine Fever Vaccines sales in global market, 2016-2021 (Estimated), (M Doses)

Key companies Classical Swine Fever Vaccines sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- WINSUN

- Merial

- CAHIC

- Chopper Biology

- MSD Animal Health (Merck)

- ChengDu Tecbond

- Ceva

- Harbin Veterinary Research Institute

- Qilu Animal Health Products Factory

- Ringpu Biology

- DHN

- CAVAC

- Komipharm

- Agrovet

- Bioveta

- Jinyu Bio-Technology

- Institutul Pasteur

- MVP

- Tecon

Classical Swine Fever Vaccines Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Classical Swine Fever Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Source
1.2.2 Market by Sales Channel
1.3 Global Classical Swine Fever Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Classical Swine Fever Vaccines Overall Market Size
2.1 Global Classical Swine Fever Vaccines Market Size: 2021 VS 2027
2.2 Global Classical Swine Fever Vaccines Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Classical Swine Fever Vaccines Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Classical Swine Fever Vaccines Players in Global Market
3.2 Top Global Classical Swine Fever Vaccines Companies Ranked by Revenue
3.3 Global Classical Swine Fever Vaccines Revenue by Companies
3.4 Global Classical Swine Fever Vaccines Sales by Companies
3.5 Global Classical Swine Fever Vaccines Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Classical Swine Fever Vaccines Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Classical Swine Fever Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Classical Swine Fever Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Classical Swine Fever Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Classical Swine Fever Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Classical Swine Fever Vaccines Market Size Markets, 2021 & 2027
4.1.2 Tissue Culture Origin
4.1.3 Cell Line Origin
4.2 By Type - Global Classical Swine Fever Vaccines Revenue & Forecasts
4.2.1 By Type - Global Classical Swine Fever Vaccines Revenue, 2016-2021
4.2.2 By Type - Global Classical Swine Fever Vaccines Revenue, 2022-2027
4.2.3 By Type - Global Classical Swine Fever Vaccines Revenue Market Share, 2016-2027
4.3 By Type - Global Classical Swine Fever Vaccines Sales & Forecasts
4.3.1 By Type - Global Classical Swine Fever Vaccines Sales, 2016-2021
4.3.2 By Type - Global Classical Swine Fever Vaccines Sales, 2022-2027
4.3.3 By Type - Global Classical Swine Fever Vaccines Sales Market Share, 2016-2027
4.4 By Type - Global Classical Swine Fever Vaccines Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Classical Swine Fever Vaccines Market Size, 2021 & 2027
5.1.2 Government Tender
5.1.3 Market Sales
5.2 By Application - Global Classical Swine Fever Vaccines Revenue & Forecasts
5.2.1 By Application - Global Classical Swine Fever Vaccines Revenue, 2016-2021
5.2.2 By Application - Global Classical Swine Fever Vaccines Revenue, 2022-2027
5.2.3 By Application - Global Classical Swine Fever Vaccines Revenue Market Share, 2016-2027
5.3 By Application - Global Classical Swine Fever Vaccines Sales & Forecasts
5.3.1 By Application - Global Classical Swine Fever Vaccines Sales, 2016-2021
5.3.2 By Application - Global Classical Swine Fever Vaccines Sales, 2022-2027
5.3.3 By Application - Global Classical Swine Fever Vaccines Sales Market Share, 2016-2027
5.4 By Application - Global Classical Swine Fever Vaccines Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Classical Swine Fever Vaccines Market Size, 2021 & 2027
6.2 By Region - Global Classical Swine Fever Vaccines Revenue & Forecasts
6.2.1 By Region - Global Classical Swine Fever Vaccines Revenue, 2016-2021
6.2.2 By Region - Global Classical Swine Fever Vaccines Revenue, 2022-2027
6.2.3 By Region - Global Classical Swine Fever Vaccines Revenue Market Share, 2016-2027
6.3 By Region - Global Classical Swine Fever Vaccines Sales & Forecasts
6.3.1 By Region - Global Classical Swine Fever Vaccines Sales, 2016-2021
6.3.2 By Region - Global Classical Swine Fever Vaccines Sales, 2022-2027
6.3.3 By Region - Global Classical Swine Fever Vaccines Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Classical Swine Fever Vaccines Revenue, 2016-2027
6.4.2 By Country - North America Classical Swine Fever Vaccines Sales, 2016-2027
6.4.3 US Classical Swine Fever Vaccines Market Size, 2016-2027
6.4.4 Canada Classical Swine Fever Vaccines Market Size, 2016-2027
6.4.5 Mexico Classical Swine Fever Vaccines Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Classical Swine Fever Vaccines Revenue, 2016-2027
6.5.2 By Country - Europe Classical Swine Fever Vaccines Sales, 2016-2027
6.5.3 Germany Classical Swine Fever Vaccines Market Size, 2016-2027
6.5.4 France Classical Swine Fever Vaccines Market Size, 2016-2027
6.5.5 U.K. Classical Swine Fever Vaccines Market Size, 2016-2027
6.5.6 Italy Classical Swine Fever Vaccines Market Size, 2016-2027
6.5.7 Russia Classical Swine Fever Vaccines Market Size, 2016-2027
6.5.8 Nordic Countries Classical Swine Fever Vaccines Market Size, 2016-2027
6.5.9 Benelux Classical Swine Fever Vaccines Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Classical Swine Fever Vaccines Revenue, 2016-2027
6.6.2 By Region - Asia Classical Swine Fever Vaccines Sales, 2016-2027
6.6.3 China Classical Swine Fever Vaccines Market Size, 2016-2027
6.6.4 Japan Classical Swine Fever Vaccines Market Size, 2016-2027
6.6.5 South Korea Classical Swine Fever Vaccines Market Size, 2016-2027
6.6.6 Southeast Asia Classical Swine Fever Vaccines Market Size, 2016-2027
6.6.7 India Classical Swine Fever Vaccines Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Classical Swine Fever Vaccines Revenue, 2016-2027
6.7.2 By Country - South America Classical Swine Fever Vaccines Sales, 2016-2027
6.7.3 Brazil Classical Swine Fever Vaccines Market Size, 2016-2027
6.7.4 Argentina Classical Swine Fever Vaccines Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Classical Swine Fever Vaccines Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Classical Swine Fever Vaccines Sales, 2016-2027
6.8.3 Turkey Classical Swine Fever Vaccines Market Size, 2016-2027
6.8.4 Israel Classical Swine Fever Vaccines Market Size, 2016-2027
6.8.5 Saudi Arabia Classical Swine Fever Vaccines Market Size, 2016-2027
6.8.6 UAE Classical Swine Fever Vaccines Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 WINSUN
7.1.1 WINSUN Corporate Summary
7.1.2 WINSUN Business Overview
7.1.3 WINSUN Classical Swine Fever Vaccines Major Product Offerings
7.1.4 WINSUN Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.1.5 WINSUN Key News
7.2 Merial
7.2.1 Merial Corporate Summary
7.2.2 Merial Business Overview
7.2.3 Merial Classical Swine Fever Vaccines Major Product Offerings
7.2.4 Merial Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.2.5 Merial Key News
7.3 CAHIC
7.3.1 CAHIC Corporate Summary
7.3.2 CAHIC Business Overview
7.3.3 CAHIC Classical Swine Fever Vaccines Major Product Offerings
7.3.4 CAHIC Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.3.5 CAHIC Key News
7.4 Chopper Biology
7.4.1 Chopper Biology Corporate Summary
7.4.2 Chopper Biology Business Overview
7.4.3 Chopper Biology Classical Swine Fever Vaccines Major Product Offerings
7.4.4 Chopper Biology Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.4.5 Chopper Biology Key News
7.5 MSD Animal Health (Merck)
7.5.1 MSD Animal Health (Merck) Corporate Summary
7.5.2 MSD Animal Health (Merck) Business Overview
7.5.3 MSD Animal Health (Merck) Classical Swine Fever Vaccines Major Product Offerings
7.5.4 MSD Animal Health (Merck) Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.5.5 MSD Animal Health (Merck) Key News
7.6 ChengDu Tecbond
7.6.1 ChengDu Tecbond Corporate Summary
7.6.2 ChengDu Tecbond Business Overview
7.6.3 ChengDu Tecbond Classical Swine Fever Vaccines Major Product Offerings
7.6.4 ChengDu Tecbond Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.6.5 ChengDu Tecbond Key News
7.7 Ceva
7.7.1 Ceva Corporate Summary
7.7.2 Ceva Business Overview
7.7.3 Ceva Classical Swine Fever Vaccines Major Product Offerings
7.4.4 Ceva Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.7.5 Ceva Key News
7.8 Harbin Veterinary Research Institute
7.8.1 Harbin Veterinary Research Institute Corporate Summary
7.8.2 Harbin Veterinary Research Institute Business Overview
7.8.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Major Product Offerings
7.8.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.8.5 Harbin Veterinary Research Institute Key News
7.9 Qilu Animal Health Products Factory
7.9.1 Qilu Animal Health Products Factory Corporate Summary
7.9.2 Qilu Animal Health Products Factory Business Overview
7.9.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Major Product Offerings
7.9.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.9.5 Qilu Animal Health Products Factory Key News
7.10 Ringpu Biology
7.10.1 Ringpu Biology Corporate Summary
7.10.2 Ringpu Biology Business Overview
7.10.3 Ringpu Biology Classical Swine Fever Vaccines Major Product Offerings
7.10.4 Ringpu Biology Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.10.5 Ringpu Biology Key News
7.11 DHN
7.11.1 DHN Corporate Summary
7.11.2 DHN Classical Swine Fever Vaccines Business Overview
7.11.3 DHN Classical Swine Fever Vaccines Major Product Offerings
7.11.4 DHN Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.11.5 DHN Key News
7.12 CAVAC
7.12.1 CAVAC Corporate Summary
7.12.2 CAVAC Classical Swine Fever Vaccines Business Overview
7.12.3 CAVAC Classical Swine Fever Vaccines Major Product Offerings
7.12.4 CAVAC Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.12.5 CAVAC Key News
7.13 Komipharm
7.13.1 Komipharm Corporate Summary
7.13.2 Komipharm Classical Swine Fever Vaccines Business Overview
7.13.3 Komipharm Classical Swine Fever Vaccines Major Product Offerings
7.13.4 Komipharm Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.13.5 Komipharm Key News
7.14 Agrovet
7.14.1 Agrovet Corporate Summary
7.14.2 Agrovet Business Overview
7.14.3 Agrovet Classical Swine Fever Vaccines Major Product Offerings
7.14.4 Agrovet Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.14.5 Agrovet Key News
7.15 Bioveta
7.15.1 Bioveta Corporate Summary
7.15.2 Bioveta Business Overview
7.15.3 Bioveta Classical Swine Fever Vaccines Major Product Offerings
7.15.4 Bioveta Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.15.5 Bioveta Key News
7.16 Jinyu Bio-Technology
7.16.1 Jinyu Bio-Technology Corporate Summary
7.16.2 Jinyu Bio-Technology Business Overview
7.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Major Product Offerings
7.16.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.16.5 Jinyu Bio-Technology Key News
7.17 Institutul Pasteur
7.17.1 Institutul Pasteur Corporate Summary
7.17.2 Institutul Pasteur Business Overview
7.17.3 Institutul Pasteur Classical Swine Fever Vaccines Major Product Offerings
7.17.4 Institutul Pasteur Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.17.5 Institutul Pasteur Key News
7.18 MVP
7.18.1 MVP Corporate Summary
7.18.2 MVP Business Overview
7.18.3 MVP Classical Swine Fever Vaccines Major Product Offerings
7.18.4 MVP Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.18.5 MVP Key News
7.19 Tecon
7.19.1 Tecon Corporate Summary
7.19.2 Tecon Business Overview
7.19.3 Tecon Classical Swine Fever Vaccines Major Product Offerings
7.19.4 Tecon Classical Swine Fever Vaccines Sales and Revenue in Global (2016-2021)
7.19.5 Tecon Key News
8 Global Classical Swine Fever Vaccines Production Capacity, Analysis
8.1 Global Classical Swine Fever Vaccines Production Capacity, 2016-2027
8.2 Classical Swine Fever Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Classical Swine Fever Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Classical Swine Fever Vaccines Supply Chain Analysis
10.1 Classical Swine Fever Vaccines Industry Value Chain
10.2 Classical Swine Fever Vaccines Upstream Market
10.3 Classical Swine Fever Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Classical Swine Fever Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Classical Swine Fever Vaccines in Global Market
Table 2. Top Classical Swine Fever Vaccines Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Classical Swine Fever Vaccines Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Classical Swine Fever Vaccines Revenue Share by Companies, 2016-2021
Table 5. Global Classical Swine Fever Vaccines Sales by Companies, (M Doses), 2016-2021
Table 6. Global Classical Swine Fever Vaccines Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Classical Swine Fever Vaccines Price (2016-2021) & (US$/K Doses)
Table 8. Global Manufacturers Classical Swine Fever Vaccines Product Type
Table 9. List of Global Tier 1 Classical Swine Fever Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Classical Swine Fever Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Classical Swine Fever Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Classical Swine Fever Vaccines Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Classical Swine Fever Vaccines Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Classical Swine Fever Vaccines Sales (M Doses), 2016-2021
Table 15. By Type - Global Classical Swine Fever Vaccines Sales (M Doses), 2022-2027
Table 16. By Application - Global Classical Swine Fever Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Classical Swine Fever Vaccines Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Classical Swine Fever Vaccines Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Classical Swine Fever Vaccines Sales (M Doses), 2016-2021
Table 20. By Application - Global Classical Swine Fever Vaccines Sales (M Doses), 2022-2027
Table 21. By Region - Global Classical Swine Fever Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Classical Swine Fever Vaccines Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Classical Swine Fever Vaccines Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Classical Swine Fever Vaccines Sales (M Doses), 2016-2021
Table 25. By Region - Global Classical Swine Fever Vaccines Sales (M Doses), 2022-2027
Table 26. By Country - North America Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Classical Swine Fever Vaccines Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Classical Swine Fever Vaccines Sales, (M Doses), 2016-2021
Table 29. By Country - North America Classical Swine Fever Vaccines Sales, (M Doses), 2022-2027
Table 30. By Country - Europe Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Classical Swine Fever Vaccines Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Classical Swine Fever Vaccines Sales, (M Doses), 2016-2021
Table 33. By Country - Europe Classical Swine Fever Vaccines Sales, (M Doses), 2022-2027
Table 34. By Region - Asia Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Classical Swine Fever Vaccines Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Classical Swine Fever Vaccines Sales, (M Doses), 2016-2021
Table 37. By Region - Asia Classical Swine Fever Vaccines Sales, (M Doses), 2022-2027
Table 38. By Country - South America Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Classical Swine Fever Vaccines Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Classical Swine Fever Vaccines Sales, (M Doses), 2016-2021
Table 41. By Country - South America Classical Swine Fever Vaccines Sales, (M Doses), 2022-2027
Table 42. By Country - Middle East & Africa Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Classical Swine Fever Vaccines Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Classical Swine Fever Vaccines Sales, (M Doses), 2016-2021
Table 45. By Country - Middle East & Africa Classical Swine Fever Vaccines Sales, (M Doses), 2022-2027
Table 46. WINSUN Corporate Summary
Table 47. WINSUN Classical Swine Fever Vaccines Product Offerings
Table 48. WINSUN Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 49. Merial Corporate Summary
Table 50. Merial Classical Swine Fever Vaccines Product Offerings
Table 51. Merial Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 52. CAHIC Corporate Summary
Table 53. CAHIC Classical Swine Fever Vaccines Product Offerings
Table 54. CAHIC Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 55. Chopper Biology Corporate Summary
Table 56. Chopper Biology Classical Swine Fever Vaccines Product Offerings
Table 57. Chopper Biology Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 58. MSD Animal Health (Merck) Corporate Summary
Table 59. MSD Animal Health (Merck) Classical Swine Fever Vaccines Product Offerings
Table 60. MSD Animal Health (Merck) Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 61. ChengDu Tecbond Corporate Summary
Table 62. ChengDu Tecbond Classical Swine Fever Vaccines Product Offerings
Table 63. ChengDu Tecbond Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 64. Ceva Corporate Summary
Table 65. Ceva Classical Swine Fever Vaccines Product Offerings
Table 66. Ceva Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 67. Harbin Veterinary Research Institute Corporate Summary
Table 68. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product Offerings
Table 69. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 70. Qilu Animal Health Products Factory Corporate Summary
Table 71. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product Offerings
Table 72. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 73. Ringpu Biology Corporate Summary
Table 74. Ringpu Biology Classical Swine Fever Vaccines Product Offerings
Table 75. Ringpu Biology Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 76. DHN Corporate Summary
Table 77. DHN Classical Swine Fever Vaccines Product Offerings
Table 78. DHN Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 79. CAVAC Corporate Summary
Table 80. CAVAC Classical Swine Fever Vaccines Product Offerings
Table 81. CAVAC Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 82. Komipharm Corporate Summary
Table 83. Komipharm Classical Swine Fever Vaccines Product Offerings
Table 84. Komipharm Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 85. Agrovet Corporate Summary
Table 86. Agrovet Classical Swine Fever Vaccines Product Offerings
Table 87. Agrovet Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 88. Bioveta Corporate Summary
Table 89. Bioveta Classical Swine Fever Vaccines Product Offerings
Table 90. Bioveta Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 91. Jinyu Bio-Technology Corporate Summary
Table 92. Jinyu Bio-Technology Classical Swine Fever Vaccines Product Offerings
Table 93. Jinyu Bio-Technology Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 94. Institutul Pasteur Corporate Summary
Table 95. Institutul Pasteur Classical Swine Fever Vaccines Product Offerings
Table 96. Institutul Pasteur Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 97. MVP Corporate Summary
Table 98. MVP Classical Swine Fever Vaccines Product Offerings
Table 99. MVP Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 100. Tecon Corporate Summary
Table 101. Tecon Classical Swine Fever Vaccines Product Offerings
Table 102. Tecon Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/K Doses) (2016-2021)
Table 103. Classical Swine Fever Vaccines Production Capacity (M Doses) of Key Manufacturers in Global Market, 2019-2021 (M Doses)
Table 104. Global Classical Swine Fever Vaccines Capacity Market Share of Key Manufacturers, 2019-2021
Table 105. Global Classical Swine Fever Vaccines Production by Region, 2016-2021 (M Doses)
Table 106. Global Classical Swine Fever Vaccines Production by Region, 2022-2027 (M Doses)
Table 107. Classical Swine Fever Vaccines Market Opportunities & Trends in Global Market
Table 108. Classical Swine Fever Vaccines Market Drivers in Global Market
Table 109. Classical Swine Fever Vaccines Market Restraints in Global Market
Table 110. Classical Swine Fever Vaccines Raw Materials
Table 111. Classical Swine Fever Vaccines Raw Materials Suppliers in Global Market
Table 112. Typical Classical Swine Fever Vaccines Downstream
Table 113. Classical Swine Fever Vaccines Downstream Clients in Global Market
Table 114. Classical Swine Fever Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Classical Swine Fever Vaccines Segment by Type
Figure 2. Classical Swine Fever Vaccines Segment by Application
Figure 3. Global Classical Swine Fever Vaccines Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Classical Swine Fever Vaccines Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Classical Swine Fever Vaccines Revenue, 2016-2027 (US$, Mn)
Figure 7. Classical Swine Fever Vaccines Sales in Global Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Classical Swine Fever Vaccines Revenue in 2020
Figure 9. By Type - Global Classical Swine Fever Vaccines Sales Market Share, 2016-2027
Figure 10. By Type - Global Classical Swine Fever Vaccines Revenue Market Share, 2016-2027
Figure 11. By Type - Global Classical Swine Fever Vaccines Price (US$/K Doses), 2016-2027
Figure 12. By Application - Global Classical Swine Fever Vaccines Sales Market Share, 2016-2027
Figure 13. By Application - Global Classical Swine Fever Vaccines Revenue Market Share, 2016-2027
Figure 14. By Application - Global Classical Swine Fever Vaccines Price (US$/K Doses), 2016-2027
Figure 15. By Region - Global Classical Swine Fever Vaccines Sales Market Share, 2016-2027
Figure 16. By Region - Global Classical Swine Fever Vaccines Revenue Market Share, 2016-2027
Figure 17. By Country - North America Classical Swine Fever Vaccines Revenue Market Share, 2016-2027
Figure 18. By Country - North America Classical Swine Fever Vaccines Sales Market Share, 2016-2027
Figure 19. US Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Classical Swine Fever Vaccines Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Classical Swine Fever Vaccines Sales Market Share, 2016-2027
Figure 24. Germany Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 25. France Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Classical Swine Fever Vaccines Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Classical Swine Fever Vaccines Sales Market Share, 2016-2027
Figure 33. China Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 37. India Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Classical Swine Fever Vaccines Revenue Market Share, 2016-2027
Figure 39. By Country - South America Classical Swine Fever Vaccines Sales Market Share, 2016-2027
Figure 40. Brazil Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Classical Swine Fever Vaccines Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Classical Swine Fever Vaccines Sales Market Share, 2016-2027
Figure 44. Turkey Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Classical Swine Fever Vaccines Revenue, (US$, Mn), 2016-2027
Figure 48. Global Classical Swine Fever Vaccines Production Capacity (M Doses), 2016-2027
Figure 49. The Percentage of Production Classical Swine Fever Vaccines by Region, 2020 VS 2027
Figure 50. Classical Swine Fever Vaccines Industry Value Chain
Figure 51. Marketing Channels
  • Global Classical Swine Fever Vaccines Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100
    It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......
  • Global Tylosin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......
  • Global Animal Parasiticides Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......
  • Global Newcastle Disease Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......
  • Global Classical Swine Fever Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126
    According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......
  • Global Veterinary Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......
  • Global Veterinary Products for Companion Animals Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......
  • Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115
    According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs